The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor

BACKGROUND: Monoamine oxidase-B (MAO-B) inhibitors are widely used in the treatment of Parkinson’s disease. They increase vital monoamine neurotransmitters in the brain. However, there is a need for safer natural reversible MAO inhibitors with MAO-B selectivity. Our previous studies showed that Psor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarmouh, Najla O., Eyunni, Suresh K., Soliman, Karam F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223566/
https://www.ncbi.nlm.nih.gov/pubmed/28069007
http://dx.doi.org/10.1186/s12906-016-1525-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223566/
https://www.ncbi.nlm.nih.gov/pubmed/28069007
http://dx.doi.org/10.1186/s12906-016-1525-y

Ejemplares similares